Literature DB >> 26130307

Distinct Metabolomic Profiles of Papillary Thyroid Carcinoma and Benign Thyroid Adenoma.

Yanan Xu1,2,3, Xiaojiao Zheng4, Yunping Qiu4, Wei Jia4, Jiadong Wang2,3, Shankai Yin1,3.   

Abstract

Papillary thyroid carcinoma (PTC) and benign thyroid adenoma (BTA) are the most common head and neck tumors. However, the metabolic differences between PTC and BTA have not been characterized. The aim of this study was to identify the metabolic profiles of these two types of tumors using a metabolomics approach. Tumors and adjacent nontumor specimens collected from 57 patients with PTC and 48 patients with BTA were profiled using gas chromatography-time-of-flight mass spectrometry and ultraperformance liquid chromatography-quadrupole time-of-flight mass spectrometry. A panel of 46 and 44 differentially expressed metabolites were identified in the PTC and BTA specimens, respetively, and compared with nontumor tissues. Common metabolic signatures, as characterized by increased glycolysis, amino acid metabolism, one carbon metabolism and tryptophan metabolism, were found in both types of tumors. Purine and pyrimidine metabolism was significantly elevated in the PTC specimens, and taurine and hypotaurine levels were also higher in the PTC tissues. Increased fatty acid and bile acid levels were found, especially in the BTA tissues. The metabolic profiles of the PTC and BTA tissues include both similar and remarkably different metabolites, suggesting the presence of common and unique mechanistic pathways in these types of tumors during tumorigenesis.

Entities:  

Keywords:  benign thyroid adenoma; gas chromatography−time-of-flight mass spectrometry; metabolomics; papillary thyroid carcinoma; ultraperformance liquid chromatography-quadrupole time-of-flight mass spectrometry

Mesh:

Substances:

Year:  2015        PMID: 26130307     DOI: 10.1021/acs.jproteome.5b00351

Source DB:  PubMed          Journal:  J Proteome Res        ISSN: 1535-3893            Impact factor:   4.466


  17 in total

Review 1.  Advances in metabolomics of thyroid cancer diagnosis and metabolic regulation.

Authors:  Raziyeh Abooshahab; Morteza Gholami; Maryam Sanoie; Fereidoun Azizi; Mehdi Hedayati
Journal:  Endocrine       Date:  2019-04-01       Impact factor: 3.633

2.  Diagnosis of post-surgical fine-needle aspiration biopsies of thyroid lesions with indeterminate cytology using HRMAS NMR-based metabolomics.

Authors:  Lamya Rezig; Adele Servadio; Liborio Torregrossa; Paolo Miccoli; Fulvio Basolo; Laetitia Shintu; Stefano Caldarelli
Journal:  Metabolomics       Date:  2018-10-10       Impact factor: 4.290

3.  Metabolomics of Oral/Head and Neck Cancer.

Authors:  Gaofei Yin; Junwei Huang; Wei Guo; Zhigang Huang
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

4.  Plasma ω-3 and ω-6 fatty acids in thyroid diseases.

Authors:  Xiang Li; Hui Li; Jing Zhao; Qi Dai; Chaoran Huang; Langping Jin; Fan Yang; Fuxue Chen; Ouchen Wang; Ying Gao
Journal:  Oncol Lett       Date:  2018-08-09       Impact factor: 2.967

5.  Tissue Metabonomic Phenotyping for Diagnosis and Prognosis of Human Colorectal Cancer.

Authors:  Yuan Tian; Tangpeng Xu; Jia Huang; Limin Zhang; Shan Xu; Bin Xiong; Yulan Wang; Huiru Tang
Journal:  Sci Rep       Date:  2016-02-15       Impact factor: 4.379

Review 6.  Metabolic Alterations of Thyroid Cancer as Potential Therapeutic Targets.

Authors:  Domenico Ciavardelli; Maria Bellomo; Ada Consalvo; Caterina Crescimanno; Veronica Vella
Journal:  Biomed Res Int       Date:  2017-11-06       Impact factor: 3.411

7.  Plasma Metabolic Profiling of Human Thyroid Nodules by Gas Chromatography-Mass Spectrometry (GC-MS)-Based Untargeted Metabolomics.

Authors:  Raziyeh Abooshahab; Kourosh Hooshmand; S Adeleh Razavi; Morteza Gholami; Maryam Sanoie; Mehdi Hedayati
Journal:  Front Cell Dev Biol       Date:  2020-06-16

Review 8.  Oncometabolites as biomarkers in thyroid cancer: a systematic review.

Authors:  Fatemeh Khatami; Moloud Payab; Masoumeh Sarvari; Kambiz Gilany; Bagher Larijani; Babak Arjmand; Seyed Mohammad Tavangar
Journal:  Cancer Manag Res       Date:  2019-02-25       Impact factor: 3.989

9.  Serum-based metabolic alterations in patients with papillary thyroid carcinoma unveiled by non-targeted 1H-NMR metabolomics approach.

Authors:  Reyhaneh Farrokhi Yekta; Mostafa Rezaei Tavirani; Afsaneh Arefi Oskouie; Mohammad Reza Mohajeri-Tehrani; Ahmad Reza Soroush; Alireza Akbarzadeh Baghban
Journal:  Iran J Basic Med Sci       Date:  2018-11       Impact factor: 2.699

Review 10.  Metabolomics-A Promising Approach to Pituitary Adenomas.

Authors:  Oana Pînzariu; Bogdan Georgescu; Carmen E Georgescu
Journal:  Front Endocrinol (Lausanne)       Date:  2019-01-17       Impact factor: 5.555

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.